tirzepatide titration
Semaglutide Is Broken - Why Tirzepatide Wins The Battle
Semaglutide Is Broken - Why Tirzepatide Wins The Battle In head-to-head trials, tirzepatide achieved 15% weight loss versus 12% for semaglutide, and a tighter titration schedule cuts nausea below 20%. Both drugs belong to the GLP-1 receptor agonist class, yet the newer dual-agonist tirzepatide shows a steeper dose-response curve and